| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 01/15/1998 | WO1998001145A1 Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
| 01/15/1998 | WO1997046673A3 Inhibition of hiv-1 replication by antisense rna expression |
| 01/15/1998 | WO1997040166A3 Simian-human hav having a chimeric 2c protein |
| 01/15/1998 | WO1997032989A3 Recombinant aav vector-based transduction system and use of same |
| 01/15/1998 | CA2260360A1 Use of a panel of heterokaryons to produce variants of multimeric proteins |
| 01/15/1998 | CA2259965A1 Hiv envelope polypeptides and vaccine |
| 01/15/1998 | CA2259158A1 Transformation-associated recombination cloning |
| 01/15/1998 | CA2259154A1 Brca1 compositions and methods for the diagnosis and treatment of breast cancer |
| 01/15/1998 | CA2258792A1 Method for producing therapeutic dna |
| 01/15/1998 | CA2231427A1 A novel human ubiquitin-conjugating enzyme technical field |
| 01/14/1998 | EP0818541A1 Species-specific detection of mycobacterium kansasii |
| 01/14/1998 | EP0818537A2 Method for cloning and producing the SapI restriction endonuclease in E. coli |
| 01/14/1998 | EP0818535A1 Novel yeast genes |
| 01/14/1998 | EP0818533A2 Novel isoform gene for focal adhesion protein paxillin |
| 01/14/1998 | EP0818531A2 Process for the preparation of K-carrageenase |
| 01/14/1998 | EP0818529A1 Spray-drying process |
| 01/14/1998 | EP0818466A2 Purified, biologically active bacterially produced recombinant human CSF-1 |
| 01/14/1998 | EP0818438A1 Chiral derivatives of hydroxyphenylglycin, and their use in the synthesis of pharmaceutical active principles |
| 01/14/1998 | EP0817863A1 Process for preparing spirolaxine and spirolaxine methyl ether |
| 01/14/1998 | EP0817861A1 Gene transfer into the kidney |
| 01/14/1998 | EP0817858A1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy |
| 01/14/1998 | EP0817855A1 Mutated proteins coded by a lentivirus mutated env gene, peptide fragments and expression vectors |
| 01/14/1998 | EP0817852A2 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein |
| 01/14/1998 | EP0817851A2 Dna encoding human papilloma virus type 18 |
| 01/14/1998 | EP0817847A1 Il-17 receptor |
| 01/14/1998 | EP0817845A1 Conditional expression system |
| 01/14/1998 | EP0817839A1 Human dnase |
| 01/14/1998 | EP0817838A1 Alkaline lipolytic enzyme |
| 01/14/1998 | EP0817644A1 Treatment of papillomavirus-associated lesions using interleukin-12 |
| 01/14/1998 | EP0817640A1 Epithelial adhesive lactobacilli |
| 01/14/1998 | EP0817567A1 Use of streptomyces bacteria to control plant pathogens and degrade turf thatch |
| 01/14/1998 | EP0771349A4 Enzyme from microbial source: phthalyl amidase |
| 01/14/1998 | EP0635061B1 A method of limiting the survival of genetically engineered microorganisms in their environment |
| 01/14/1998 | EP0394277B1 Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same |
| 01/14/1998 | EP0379556B1 Production of glucose oxidase in recombinant systems |
| 01/14/1998 | CN1170415A Cathepsin O2 protease |
| 01/13/1998 | US5708159 Probe for diagnosing infectious diseases which hybridizes with DNA from candida albicans |
| 01/13/1998 | US5708149 Method for producing purified recombinant Haemophilus influenzae transferrin binding proteins |
| 01/13/1998 | US5708148 Mutants of escherichia coli cells, denaturing polypeptides, refolding and incubation |
| 01/13/1998 | US5708147 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis |
| 01/13/1998 | US5708143 Protocadherin materials and methods |
| 01/13/1998 | US5708140 Production of proteins using 7B2 protein |
| 01/13/1998 | US5708139 Pseudomonas syringae pv syringae hrpZ gene |
| 01/13/1998 | US5708134 Human AlaGlu-IGF-1 |
| 01/13/1998 | US5707950 Detergent compositions containing lipase and protease |
| 01/13/1998 | US5707866 Dna with rna for antisense oligomers |
| 01/13/1998 | US5707865 Retroviral vectors for expression in embryonic cells |
| 01/13/1998 | US5707862 Shuttle vector |
| 01/13/1998 | US5707854 Lactic acid bacteria of the Genus lactobacillus |
| 01/13/1998 | US5707846 N-acetylglucosaminyl transferase gene coding therefor and process for production thereof |
| 01/13/1998 | US5707844 Immunoassay reagents and methods for detecting brequinar and analogs |
| 01/13/1998 | US5707841 Process of producing highly transformable bacterial cells and cells produced thereby |
| 01/13/1998 | US5707839 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
| 01/13/1998 | US5707828 Expression of human serum albumin in Pichia pastoris |
| 01/13/1998 | US5707827 Mutant AOX2 promoter, vector carrying same, transformant and production of heterologous protein |
| 01/13/1998 | US5707826 Transpeptidation, replacing terminal portion of peptide sequence with another sequence, forming amide at c-terminal position in one step |
| 01/13/1998 | US5707825 Interface bioreactor system |
| 01/13/1998 | US5707822 Polypeptide with apolipoproteinase activity with culture of prokaryotic unicellar organisms containing plasmids with dna sequence codes |
| 01/13/1998 | US5707815 Polypeptides produced bby expression of heterologous nucleic acid in cells and encoded by dna and hybridize |
| 01/13/1998 | US5707805 Assay for detecting keratinocyte growth factor (KGF) and its activity |
| 01/13/1998 | US5707800 Retinoic acid response elements and assays employing same |
| 01/13/1998 | US5707632 Immunology |
| 01/13/1998 | US5707618 Adenovirus vectors for gene therapy |
| 01/09/1998 | CA2209527A1 Process for preparing k-carraghenase |
| 01/08/1998 | WO1998000548A1 Hepatitis c surrogate virus for testing the activity of hepatitis c virus protease, a recombinant gene and a use thereof |
| 01/08/1998 | WO1998000529A1 A recombinant enzyme with dextranase activitiy |
| 01/08/1998 | WO1998000528A1 A recombinant enzyme with mutanase activity |
| 01/08/1998 | WO1998000445A1 Nephropathy-related immunoglobulin g and antibodies for same |
| 01/08/1998 | WO1998000166A1 Recombinant canine adenovirus (cav) containing exogenous dna |
| 01/08/1998 | CA2259302A1 Nephropathy-related immunoglobulin g and immune complexes thereof |
| 01/08/1998 | CA2258292A1 A recombinant enzyme with dextranase activitiy |
| 01/08/1998 | CA2258291A1 A recombinant enzyme with mutanase activity |
| 01/08/1998 | CA2205554A1 Novel isoform gene for focal adhesion protein paxillin |
| 01/07/1998 | EP0816508A1 Preparation of oligo- or polynucleotides, 2'-deoxy- or 2',3'-dideoxyfuranosides and desamino compounds of nucleosides, nucleotides, purine and pyrimidine bases by means of multifunctional enzymes |
| 01/07/1998 | EP0816506A1 System for the expression of heterologous antigens as fusion proteins |
| 01/07/1998 | EP0816505A1 Structural proteins from artificial genes |
| 01/07/1998 | EP0816504A2 Platelet activating factor acetylhdrolase, and gene thereof |
| 01/07/1998 | EP0816502A2 Mur A-1, an UDP-N-acetylglucosamine enolpyruvyl-transferase from Streptococcus pneumoniae |
| 01/07/1998 | EP0816500A2 Process for controlling scarab pests with bacillus thuringiensis isolates |
| 01/07/1998 | EP0816497A2 Human requiem polypeptide for apoptosis |
| 01/07/1998 | EP0816496A2 T-cells specific for kidney carcinoma |
| 01/07/1998 | EP0816495A1 DNA coding for a peptide promoting the activation of protein C by thrombin and dprocess for producing the same |
| 01/07/1998 | EP0816494A1 DNA coding for a peptide promoting the activation of protein C by thrombin, and process for producing the same |
| 01/07/1998 | EP0816493A1 3'End deleted DNA coding for a peptide promoting the activation of protein C by thrombin, and process for producing the same |
| 01/07/1998 | EP0816490A2 Mutant prenyl diphosphate synthase |
| 01/07/1998 | EP0816489A1 Nucleotidesugar synthesizing enzyme from non-parasitic protists |
| 01/07/1998 | EP0815872A2 Compounds for targeting |
| 01/07/1998 | EP0815255A1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae |
| 01/07/1998 | EP0815252A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
| 01/07/1998 | EP0815251A1 Gene expression in mammalian cells |
| 01/07/1998 | EP0815247A1 Method for the production of cationic peptides |
| 01/07/1998 | EP0815246A1 Methods and compositions for secretion of heterologous polypeptides |
| 01/07/1998 | EP0815245A1 Bioactive fusion proteins and pre-existing tumor therapy |
| 01/07/1998 | EP0815244A1 Thermitase variants having decreased adsorption and increased hydrolysis |
| 01/07/1998 | EP0815243A2 Subtilisin dy variants having decreased adsorption and increased hydrolysis |
| 01/07/1998 | EP0815242A1 Endo beta-1,4-glucanase from aspergillus |
| 01/07/1998 | EP0815241A1 Identification and cloning of a mobile transposon from aspergillus |
| 01/07/1998 | EP0815237A1 Threonyl-trna synthetase of staphylococcus aureus |
| 01/07/1998 | EP0815236A1 Haemophilus adhesion proteins |
| 01/07/1998 | EP0815234A1 Proteinase k resistant surface protein of neisseria meningitidis |